Fisher & Paykel Healthcare Corp Ltd (fra:FPLB) Share Price

Company Profile

Business description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 27% in Europe, 21% in Asia-Pacific, and the remaining 10% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Contact
15 Maurice Paykel Place
East Tamaki
AucklandNTL2013
NZL
T: +64 95740100
E: [email protected]
https://www.fphcare.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 March 2026
Employees
7,440

Recommended

AI is reshaping ASX tech moats - but some are more insulated than others.

Tyger Fitzpatrick | 22 March 2026

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.

Dan Romanoff, CPA | 20 March 2026

Sims guides huge earnings upgrade as data center metals demand spikes.

Esther Holloway | 20 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,552.20	76.60	0.90%
CAC 40	7,665.62	142.25	-1.82%
DAX 40	22,380.19	459.37	-2.01%
Dow JONES (US)	45,577.47	443.96	-0.96%
FTSE 100	9,918.33	145.17	-1.44%
HKSE	24,444.50	832.82	-3.29%
NASDAQ	21,647.61	443.08	-2.01%
Nikkei 225	51,582.23	1,790.30	-3.35%
NZX 50 Index	12,896.50	93.49	-0.72%
S&P 500	6,506.48	100.01	-1.51%
S&P/ASX 200	8,365.40	81.90	0.99%
SSE Composite Index	3,871.11	85.95	-2.17%